Physician profile
Earl D Brown
NPI 1558368696
$2,373.11
in general payments reported to CMS, 2019-2025
17 companies · $26.52 in 2025
The $26.52 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $334 · 2021: $509 · 2022: $927 · 2023: $52.36 · 2024: $71.15 · 2025: $26.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,100.16 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $230.11 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $195.86 | 2019-2022 | |
| Daiichi Sankyo INC. | $150.03 | 2023-2025 | Injectafer |
| Redhill Biopharma INC. | $132.78 | 2020 | |
| Gilead Sciences, INC. | $105.52 | 2019-2022 | |
| Janssen Biotech, INC. | $88.87 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $75.51 | 2021-2022 | |
| Pfizer INC. | $63.78 | 2019 | |
| Merck Sharp & Dohme LLC | $48.77 | 2021-2022 | |
| Braintree Laboratories, INC. | $42.60 | 2019-2021 | |
| Genzyme Corporation | $33.30 | 2022 | |
| Ferring Pharmaceuticals INC. | $27.80 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $25.51 | 2020 | |
| Ironwood Pharmaceuticals, INC | $18.85 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $16.92 | 2019 | |
| Shire North American Group INC | $16.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Earl Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.